Townes, Ashley http://orcid.org/0000-0002-5949-1305
Pyra, Maria
Smith, Dawn K.
Babu, Aruna Surendera
Williams, Tiffany
Wiener, Jeffrey
Henny, Kirk D.
Schneider, John
Funding for this research was provided by:
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention)
Article History
Accepted: 21 August 2022
First Online: 12 September 2022
Declarations
:
: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This analysis was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the Centers for Disease Control and Prevention.
: No financial relationships relevant to this article to disclose.
: The authors declare that they have no relevant financial or nonfinancial conflicts of interest to disclose.
: The SHIPP Study received human subjects research review and approval by the CDC IRB and the IRB of the City of Philadelphia IRB and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: All participants in the SHIPP medication adherence substudy (MAS) provided written informed consent for data and specimen collection and for publication of anonymized data.
: Not applicable.